Cantor Fitzgerald Reiterates Neutral on Incyte
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Eric Schmidt has reiterated a Neutral rating on Incyte (NASDAQ:INCY).
September 16, 2024 | 12:29 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cantor Fitzgerald's analyst Eric Schmidt has reiterated a Neutral rating on Incyte, indicating no change in the firm's outlook on the stock.
The reiteration of a Neutral rating suggests that Cantor Fitzgerald does not see significant short-term catalysts for Incyte's stock price to move up or down. This maintains the status quo for investors, indicating a balanced view of potential risks and rewards.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100